HSA — authorised 13 July 1984
- Marketing authorisation holder: BRAINTREE
- Status: likely_approved
HSA authorised Miralax on 13 July 1984
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 13 July 1984.
BRAINTREE holds the Singaporean marketing authorisation.